May 14, 2021 Cellectar to Participate at the Oppenheimer Rare & Orphan Disease Summit on May 21, 2021 Learn More
May 10, 2021 Cellectar Reports Financial Results for the First Quarter 2021 and Provides a Corporate Update Learn More
Apr 27, 2021 Cellectar Strengthens Global IP Position with Phospholipid Drug Conjugate Composition of Matter Patent in Eurasia, Australia, and Mexico Learn More